A critical advance in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial malignant suppressor protein is frequently disabled in several kinds of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research